Access to medicines: Will history repeat itself?
January 19, 2021Rebutting pharma’s rejection of a global COVID-19 IP waiver By Felipe Carvalho, Yuanqiong Hu, Leena Menghaney In response to the COVID-19 “TRIPS waiver” proposal submitted by South Africa and India for a temporary waiver from certain pharmaceutical intellectual property (IP) obligations at...
Read more
COVID-19: Governments must act fast on consensus supporting historic move to suspend monopolies during pandemic
December 15, 2020Over 100 countries support the landmark proposal Geneva —Ahead of a critical meeting at the World Trade Organization (WTO) tomorrow — and against the backdrop of COVID-19 cases surging globally — the international medical humanitarian organisation Médecins Sans Frontières /Doctors...
Read more
COVID-19: Pfizer and Moderna vaccines can only be scaled up globally if many more suppliers can produce
December 8, 2020Geneva – As the US Food and Drug Administration (FDA) starts meeting today and later this month to discuss emergency use authorisation of both the Pfizer/BioNTech and Moderna COVID-19 vaccine candidates, Médecins Sans Frontières/Doctors Without Borders (MSF) warns that any eventual...
Read more
MSF: Governments must demand pharma make all COVID-19 vaccine licensing deals public
November 11, 2020Terms of a deal disclosed show that we cannot rely on pharma’s goodwill to do the right thing, even in a pandemic. Geneva, 11 November 2020 – After the worrying terms of a deal struck between pharmaceutical corporation AstraZeneca and...
Read more
5 reasons a new proposal by India and South Africa could be a gamechanger in the COVID-19 response
October 11, 20205 reasons a new proposal by India and South Africa could be a gamechanger in the COVID-19 response. And why ALL governments should support it. On October 2, 2020, India and South Africa submitted a landmark proposal to the World Trade...
Read more
COVID-19 vaccine: 6 recommendations for equitable access
June 22, 2020We're in a time of unprecedented mobilisation to tackle COVID-19. We're in a time of unprecedented mobilisation to tackle COVID-19. Governments and philanthropies have contributed billions to the research and development of COVID-19 vaccines, while Gavi, the Vaccine Alliance, has recently launched...
Read more
